NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

DURECT Corporation (NASDAQ: DRRX)

 
DRRX Technical Analysis
5
As on 9th Jun 2023 DRRX SHARE Price closed @ 5.64 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.60 & Strong Buy for SHORT-TERM with Stoploss of 0.76 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

DRRXSHARE Price

Open 5.83 Change Price %
High 6.01 1 Day -0.11 -1.91
Low 5.60 1 Week -0.51 -8.29
Close 5.64 1 Month 1.52 36.89
Volume 185200 1 Year 4.67 481.44
52 Week High 8.72 | 52 Week Low 0.38
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
DRRX
Daily Charts
DRRX
Intraday Charts
Whats New @
Bazaartrend
DRRX
Free Analysis
 
DRRX Important Levels Intraday
RESISTANCE6.43
RESISTANCE6.18
RESISTANCE6.02
RESISTANCE5.86
SUPPORT5.42
SUPPORT5.26
SUPPORT5.10
SUPPORT4.85
 
DRRX Forecast April 2024
4th UP Forecast6.18
3rd UP Forecast6.01
2nd UP Forecast5.9
1st UP Forecast5.79
1st DOWN Forecast5.49
2nd DOWN Forecast5.38
3rd DOWN Forecast5.27
4th DOWN Forecast5.1
 
DRRX Weekly Forecast
4th UP Forecast5.91
3rd UP Forecast5.82
2nd UP Forecast5.77
1st UP Forecast5.72
1st DOWN Forecast5.56
2nd DOWN Forecast5.51
3rd DOWN Forecast5.46
4th DOWN Forecast5.37
 
DRRX Forecast2024
4th UP Forecast23.25
3rd UP Forecast17.6
2nd UP Forecast14.11
1st UP Forecast10.62
1st DOWN Forecast0.66
2nd DOWN Forecast-2.83
3rd DOWN Forecast-6.32
4th DOWN Forecast-11.97
 
 
DRRX Other Details
Segment EQ
Market Capital 276407648.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
DRRX Address
DRRX
 
DRRX Latest News
 
Your Comments and Response on DURECT Corporation
 
DRRX Business Profile
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops DUR-928, an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid homeostasis, inflammation, and cell survival, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; Santen Pharmaceutical Co., Ltd.; Sandoz AG; and Gilead Sciences, Inc. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California. Address: 10260 Bubb Road, Cupertino, CA, United States, 95014-4166
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service